HealthInc42about 2 hours ago
Honasa Calls Off ₹135 Cr Fluence Pharma Deal
3 min read
Honasa Consumer called off its ₹135 Cr acquisition of a 58% stake in Fluence Pharma after closing conditions were unmet. The Mamaearth parent remains committed to nutraceuticals and will pursue other opportunities in the category.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
